SONIA QUINONEZ-NAVA: Open Payments
NPI 1245828748 · SCOTTSDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$6,389 in 198 payments from 46 companies in 2025. Trend: 2023 $0 · 2024 $3,680 · 2025 $6,389
Food & beverage: $6,356Education: $33
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 17 | $656 |
| AstraZeneca Pharmaceuticals LP | 16 | $512 |
| Janssen Biotech, Inc. | 14 | $502 |
| Daiichi Sankyo Inc. | 14 | $480 |
| Merck Sharp & Dohme LLC | 12 | $337 |
| GENZYME CORPORATION | 5 | $326 |
| BeOne Medicines USA, Inc. | 3 | $308 |
| SpringWorks Therapeutics, Inc. | 6 | $255 |
| ABBVIE INC. | 12 | $251 |
| Novartis Pharmaceuticals Corporation | 11 | $225 |
Products named: KEYTRUDA, JAKAFI, TEVIMBRA, WAYRILZ, OGSIVEO, ENHERTU, MONJUVI, TECVAYLI.
Industry payments across AZ — which companies pay providers there.
